Business Insider

Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and ...

WATERTOWN, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing ...
manilatimes

UPDATE -- Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316 ...

Acrivon is a clinical stage biopharmaceutical company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 platform. The platform allows the ...
GameSpot

Amid Modern Warfare 4 Rumors, CoD Dev Says Not To Believe Everything On The Internet

GameSpot may get a commission from retail offers. Infinity Ward, the developer of the popular Call of Duty: Modern Warfare series, has told fans, "Don't believe everything you read on the internet" ...
Game Rant

Call of Duty 2026 Gets Discouraging Update from Trusted Leaker

Dominik Bošnjak is a freelance writer from Croatia. He has been writing about games for as long as he can remember and began doing so professionally circa 2010. If he was forced to pick a favorite ...